Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for res-Reference-Cited by-同舟云学术

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for res

Published:2015-05-29 Issue:17 Volume:121 Page:2933-2941
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Coens Corneel¹,van der Graaf Winette T. A.²,Blay Jean-Yves³,Chawla Sant P.⁴,Judson Ian⁵,Sanfilippo Roberta⁶,Manson Stephanie C.⁷,Hodge Rachel A.⁷,Marreaud Sandrine⁸,Prins Judith B.⁹,Lugowska Iwona¹⁰¹¹,Litière Saskia¹,Bottomley Andrew¹

Affiliation:

1. Department of Biostatistics; European Organization for Research and Treatment of Cancer; Brussels Belgium

2. Department of Medical Oncology; Radboud University Medical Center; Nijmegen the Netherlands

3. Centre Léon Bérard, Université Claude Bernard Lyon; Lyon France

4. Sarcoma Oncology Center; Santa Monica Oncology Center; Santa Monica California

5. Sarcoma Unit; Royal Marsden Hospital; London United Kingdom

6. National Cancer Institute of Milan; Foundation for the Scientific Institute for Research, Hospitalization, and Health Care; Milan Italy

7. GlaxoSmithKline Oncology; Uxbridge United Kingdom

8. Medical and Pharmacovigilance Department; European Organization for Research and Treatment of Cancer; Brussels Belgium

9. Department of Medical Psychology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

10. Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology; Warsaw Poland

11. Institute of Mother and Child; Warsaw Poland

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29426/fullpdf

Reference37 articles.

1. Soft-tissue sarcomas in adults;Clark;N Engl J Med,2005

2. Quality of life and utility in patients with metastatic soft tissue and bone sarcoma: the Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study [serial online];Reichardt;Sarcoma,2012

3. Elicitation of health state utilities in soft tissue sarcoma;Shingler;Qual Life Res,2013

4. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002

5. Histology-driven chemotherapy in soft tissue sarcomas;Scurr;Curr Treat Options Oncol,2011

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma;BMC Cancer;2023-07-08

2. REAL-LIFE DATA OF PAZOPANIB USAGE IN SOFT TISSUE SARCOMA;Turkish Journal of Clinics and Laboratory;2023-06-30

3. Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311);Frontiers in Oncology;2023-05-10

4. Clinical markers of immunotherapy outcomes in advanced sarcoma;BMC Cancer;2023-04-07

5. Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment;Cancers;2023-02-15